179 related articles for article (PubMed ID: 34198834)
21. The cytotoxic, apoptotic and oxidative effects of carbonic anhydrase IX inhibitor on colorectal cancer cells.
Tülüce Y; Ahmed BA; Koyuncu İ; Durgun M
J Bioenerg Biomembr; 2018 Apr; 50(2):107-116. PubMed ID: 29520697
[TBL] [Abstract][Full Text] [Related]
22. Activation of carbonic anhydrase IX by alternatively spliced tissue factor under late-stage tumor conditions.
Ramchandani D; Unruh D; Lewis CS; Bogdanov VY; Weber GF
Lab Invest; 2016 Dec; 96(12):1234-1245. PubMed ID: 27721473
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological Inhibition of CA-IX Impairs Tumor Cell Proliferation, Migration and Invasiveness.
Ciccone V; Filippelli A; Angeli A; Supuran CT; Morbidelli L
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340282
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX.
Aneja B; Queen A; Khan P; Shamsi F; Hussain A; Hasan P; Rizvi MMA; Daniliuc CG; Alajmi MF; Mohsin M; Hassan MI; Abid M
Bioorg Med Chem; 2020 May; 28(9):115424. PubMed ID: 32209296
[TBL] [Abstract][Full Text] [Related]
25. Effect of Carbonic Anhydrase IX inhibitors on human endothelial cell survival.
Genah S; Angeli A; Supuran CT; Morbidelli L
Pharmacol Res; 2020 Sep; 159():104964. PubMed ID: 32485281
[TBL] [Abstract][Full Text] [Related]
26. CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target.
Drenckhan A; Freytag M; Supuran CT; Sauter G; Izbicki JR; Gros SJ
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1024-1033. PubMed ID: 29865880
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity.
Riemann A; Güttler A; Haupt V; Wichmann H; Reime S; Bache M; Vordermark D; Thews O
Oncol Res; 2018 Mar; 26(2):191-200. PubMed ID: 28631600
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological investigation of new carbonic anhydrase IX (CAIX) inhibitors.
Vanchanagiri K; Emmerich D; Bruschke M; Bache M; Seifert F; Csuk R; Vordermark D; Paschke R
Chem Biol Interact; 2018 Mar; 284():12-23. PubMed ID: 29454615
[TBL] [Abstract][Full Text] [Related]
29. Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer.
Eldehna WM; Nocentini A; Al-Rashood ST; Hassan GS; Alkahtani HM; Almehizia AA; Reda AM; Abdel-Aziz HA; Supuran CT
Bioorg Chem; 2018 Dec; 81():425-432. PubMed ID: 30219719
[TBL] [Abstract][Full Text] [Related]
30. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
[TBL] [Abstract][Full Text] [Related]
31. High-Affinity NIR-Fluorescent Inhibitors for Tumor Imaging via Carbonic Anhydrase IX.
Žvinys G; Petrosiute A; Zakšauskas A; Zubrienė A; Ščerbavičienė A; Kalnina Z; Čapkauskaitė E; Juozapaitienė V; Mickevičiu Tė A; Shubin K; Grincevičienė Š; Raišys S; Tars K; Matulienė J; Matulis D
Bioconjug Chem; 2024 Jun; 35(6):790-803. PubMed ID: 38750635
[TBL] [Abstract][Full Text] [Related]
32. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers.
Marks IS; Gardeen SS; Kurdziel SJ; Nicolaou ST; Woods JE; Kularatne SA; Low PS
Mol Pharm; 2018 Jun; 15(6):2289-2296. PubMed ID: 29715036
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma.
Todenhöfer T; Gibb EA; Seiler R; Kamyabi A; Hennenlotter J; McDonald P; Moskalev I; Stewart C; Gao J; Fazli L; Dedhar S; Stenzl A; Oo HZ; Black PC
Urol Oncol; 2021 Aug; 39(8):498.e1-498.e11. PubMed ID: 34083096
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and mechanism study of coumarin-sulfonamide derivatives as carbonic anhydrase IX inhibitors with anticancer activity.
Lv Q; Zhang J; Cai J; Chen L; Liang J; Zhang T; Lin J; Chen R; Zhang Z; Guo P; Hong Y; Pan L; Ji H
Chem Biol Interact; 2024 Apr; 393():110947. PubMed ID: 38479716
[TBL] [Abstract][Full Text] [Related]
35. Valproic acid inhibits the growth of HeLa cervical cancer cells via caspase-dependent apoptosis.
Han BR; You BR; Park WH
Oncol Rep; 2013 Dec; 30(6):2999-3005. PubMed ID: 24064712
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis.
Yu SJ; Yoon JH; Lee JH; Myung SJ; Jang ES; Kwak MS; Cho EJ; Jang JJ; Kim YJ; Lee HS
Acta Pharmacol Sin; 2011 Jul; 32(7):912-20. PubMed ID: 21666701
[TBL] [Abstract][Full Text] [Related]
37. Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX.
Murri-Plesko MT; Hulikova A; Oosterwijk E; Scott AM; Zortea A; Harris AL; Ritter G; Old L; Bauer S; Swietach P; Renner C
Eur J Pharmacol; 2011 Apr; 657(1-3):173-83. PubMed ID: 21315712
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effect of fisetin combined with sorafenib in human cervical cancer HeLa cells through activation of death receptor-5 mediated caspase-8/caspase-3 and the mitochondria-dependent apoptotic pathway.
Lin MT; Lin CL; Lin TY; Cheng CW; Yang SF; Lin CL; Wu CC; Hsieh YH; Tsai JP
Tumour Biol; 2016 May; 37(5):6987-96. PubMed ID: 26662956
[TBL] [Abstract][Full Text] [Related]
39. A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer.
Ruzzolini J; Laurenzana A; Andreucci E; Peppicelli S; Bianchini F; Carta F; Supuran CT; Romanelli MN; Nediani C; Calorini L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):391-397. PubMed ID: 31865754
[TBL] [Abstract][Full Text] [Related]
40. Targeting CAIX with [
Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
